Joel Gabre, CUIMC
iPSC approaches to investigate esophageal development and disease
iPSC approaches to investigate esophageal development and disease
Translating microbiota research into therapies for liver disease
Host Adaptations to Microbial Diversity
Connection of Liver Inflammation with Metabolic Dysfunctions by PU.1
Integrated Multi-Omics Approaches to Identify Novel Mechanisms Underlying Functional GI Disorders
Theme 1: Epithelial homeostasis and regeneration Chairs: Timothy Wang, MD and Ira Tabas, MD, PhD • 10:10:10:30am Ira Tabas, MD, PhD "The Role of TAZ in NASH" • 10:30-10:50am Utpal Pajvani, MD "Novel therapeutic targets for NASH" • 10:50-11:10am DLDRC Pilot & Feasibility Grant awardee talk: Dominique Bailey, MD "Immune modeling of Pediatric Eosinophilic Esophagitis" […]
Pruritogenic receptors: Putting the irritant into Irritable Bowel Syndrome?
The Brain Gut Microbiome System – Implications for GI disorders
Amanda Decker (PhD candidate, Olive lab): “Bacterial Toxin Therapy for Pancreatic Ductal Adenocarcinoma” Aveline Filliol, PhD ( Schwabe Lab): “Dual functions of stellate cells in the injured liver” Ermanno Malagola, PhD (Timothy Wang Lab):“Investigating intestinal stem cell heterogeneity”
Antibiotic-resistant gut bacteria and their crosstalk in the ICU